Special articleCanadian Cardiovascular Society Consensus Conference recommendations on heart failure update 2007: Prevention, management during intercurrent illness or acute decompensation, and use of biomarkersMise à jour des recommandations issues de la Conférence de 2007 de la Société canadienne de cardiologie pour un consensus sur l’insuffisance cardiaque : Prévention, prise en charge lors de maladie intercurrente ou de décompensation aiguë et utilisation des biomarqueurs
References (239)
- et al.
Canadian Cardiovascular Society consensus conference recommendations on heart failure 2006: Diagnosis and management
Can J Cardiol
(2006) - et al.
Epidemiology of diastolic heart failure
Prog Cardiovasc Dis
(2005) - et al.
Effects of candesartan in patients with chronic heart failure and preserved left-ventricular ejection fraction: The CHARM-Preserved Trial
Lancet
(2003) - et al.
Enhanced external counterpulsation improves exercise tolerance in patients with chronic heart failure
J Am Coll Cardiol
(2006) - et al.
Effect of enalapril on 12-year survival and life expectancy in patients with left ventricular systolic dysfunction: A follow-up study
Lancet
(2003) - et al.
Role of diabetes in congestive heart failure: The Framingham study
Am J Cardiol
(1974) - et al.
Effect of enalapril on myocardial infarction and unstable angina in patients with low ejection fractions
Lancet
(1992) - et al.
Effects of statin therapy on the development and progression of heart failure: Mechanisms and clinical trials
J Card Fail
(2006) - et al.
The effects of simvastatin on the incidence of heart failure in patients with coronary heart disease
J Card Fail
(1997) - et al.
Frequency of congestive heart failure in older persons with prior myocardial infarction and serum low-density lipoprotein cholesterol > or = 125 mg/dL treated with statins versus no lipid-lowering drug
Am J Cardiol
(2002)
Canadian Cardiovascular Society position statement – recommendations for the diagnosis and treatment of dyslipidemia and prevention of cardiovascular disease
Can J Cardiol
(2006)
Hypertension and smoking are associated with reduced regional left ventricular function in asymptomatic individuals: The multi-ethnic study of atherosclerosis
J Am Coll Cardiol
(2006)
Relationship of current and past smoking to mortality and morbidity in patients with left ventricular dysfunction
J Am Coll Cardiol
(2001)
Impact of obesity on the risk of heart failure and survival after the onset of heart failure
Med Clin North Am
(2004)
Relation of duration of morbid obesity to left ventricular mass, systolic function, and diastolic filling, and effect of weight loss
Am J Cardiol
(1995)
Cardiac morphology and left ventricular function in normotensive morbidly obese patients with and without congestive heart failure, and effect of weight loss
Am J Cardiol
(1997)
Effect of weight loss on left ventricular diastolic filling in morbid obesity
Am J Cardiol
(1995)
Weight loss of 146 kg with diet and reversal of severe congestive heart failure in a young, morbidly obese patient
Am J Cardiol
(1999)
Plasma brain natriuretic peptide concentration: Impact of age and gender
J Am Coll Cardiol
(2002)
Predictive value of systolic and diastolic function for incident congestive heart failure in the elderly: The cardiovascular health study
J Am Coll Cardiol
(2001)
A population-based assessment of left ventricular systolic dysfunction in middle-aged and older adults: The Strong Heart Study
Am Heart J
(2001)
Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): A randomised controlled trial
Lancet
(2005)
Incidence, predictors at admission, and impact of worsening renal function among patients hospitalized with heart failure
J Am Coll Cardiol
(2004)
Clinical relevance and management of the major electrolyte abnormalities in congestive heart failure: Hyponatremia, hypokalemia, and hypomagnesemia
Am Heart J
(1994)
Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as bolus in refractory congestive heart failure: Long-term effects
Am Heart J
(2003)
Prolonged therapy by the combination of furosemide and thiazides in refractory heart failure and other fluid retaining conditions
Int J Cardiol
(1995)
Outcome of heart failure with preserved ejection fraction in a population-based study
N Engl J Med
(2006)
Trends in prevalence and outcome of heart failure with preserved ejection fraction
N Engl J Med
(2006)
Systolic and diastolic heart failure in the community
JAMA
(2006)
The perindopril in elderly people with chronic heart failure (PEP-CHF) study
Eur Heart J
(2006)
Digoxin and reduction in mortality and hospitalization in heart failure: A comprehensive post hoc analysis of the DIG trial
Eur Heart J
(2006)
Randomized trial to determine the effect of nebivolol on mortality and cardiovascular hospital admission in elderly patients with heart failure (SENIORS)
Eur Heart J
(2005)
Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions
N Engl J Med
(1992)
The progression from hypertension to congestive heart failure
JAMA
(1996)
Heart failure: The frequent, forgotten, and often fatal complication of diabetes
Diabetes Care
(2003)
Effects of different blood-pressure-lowering regimens on major cardiovascular events: Results of prospectively designed overviews of randomised trials
Lancet
(2003)
Coronary artery disease as the cause of incident heart failure in the population
Eur Heart J
(2001)
Therapies to prevent heart failure post-myocardial infarction
Current Heart Fail Rep
(2005)
Effects of captopril on ischemic events after myocardial infarction. Results of the Survival and Ventricular Enlargement trial. SAVE Investigators
Circulation
(1994)
Risk factors for congestive heart failure in US men and women: NHANES I epidemiologic follow-up study
Arch Intern Med
(2001)
Incidence of newly diagnosed heart failure in UK general practice
Eur J Heart Fail
(2001)
The incidence of congestive heart failure in type 2 diabetes: An update
Diabetes Care
(2004)
Development of congestive heart failure in type 2 diabetic patients with microalbuminuria or proteinuria: Observations from the DIABHYCAR (type 2 DIABetes, Hypertension. CArdiovascular Events and Ramipril) study
Diabetes Care
(2003)
Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): Prospective observational study
BMJ
(2000)
Glycemic control and heart failure among adult patients with diabetes
Circulation
(2001)
Intensive bloodglucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)
Lancet
(1998)
Canadian Diabetes Association 2003 clinical practice guidelines for the prevention and management of diabetes in Canada
Can J Diabetes
(2003)
Risk factors for heart failure in the general population: The study of men born in 1913
Eur Heart J
(1989)
Cited by (114)
Disposition of acute decompensated heart failure from the emergency department: An evidence-based review
2021, American Journal of Emergency Medicine2017 Comprehensive Update of the Canadian Cardiovascular Society Guidelines for the Management of Heart Failure
2017, Canadian Journal of CardiologyCitation Excerpt :Physical examination evaluates systemic perfusion and presence of congestion.182,405-407 Laboratory testing, ECG, chest x-ray, and ECHO are all important to obtain relatively efficiently.406 Clinicians should consider potential etiology and precipitating factors (Table 3).
Clinical benefits of natriuretic peptides and galectin-3 are maintained in old dyspnoeic patients
2017, Archives of Gerontology and GeriatricsFactors Associated With Natriuretic Peptide Testing in Patients Presenting to Emergency Departments With Suspected Heart Failure
2016, Canadian Journal of CardiologyThe Canadian Cardiovascular Society Heart Failure Companion: Bridging Guidelines to Your Practice
2016, Canadian Journal of Cardiology
Copyright © 2007 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.